- Home
- BMRN vs CART Comparison
BMRN vs CART Comparison
Compare BMRN & CART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- CART
- Stock Information
- Founded
- BMRN 1996
- CART 2012
- Country
- BMRN United States
- CART United States
- Employees
- BMRN N/A
- CART N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- CART
- Sector
- BMRN Health Care
- CART
- Exchange
- BMRN Nasdaq
- CART Nasdaq
- Market Cap
- BMRN 10.0B
- CART 12.2B
- IPO Year
- BMRN 1999
- CART 2023
- Fundamental
- Price
- BMRN $51.52
- CART $36.62
- Analyst Decision
- BMRN Buy
- CART Buy
- Analyst Count
- BMRN 19
- CART 26
- Target Price
- BMRN $90.26
- CART $53.46
- AVG Volume (30 Days)
- BMRN 2.8M
- CART 5.1M
- Earning Date
- BMRN 10-27-2025
- CART 11-10-2025
- Dividend Yield
- BMRN N/A
- CART N/A
- EPS Growth
- BMRN 59.53
- CART N/A
- EPS
- BMRN 2.68
- CART 1.73
- Revenue
- BMRN $3,094,001,000.00
- CART $3,546,000,000.00
- Revenue This Year
- BMRN $13.32
- CART $12.29
- Revenue Next Year
- BMRN $7.51
- CART $9.57
- P/E Ratio
- BMRN $19.20
- CART $21.23
- Revenue Growth
- BMRN 12.39
- CART 10.47
- 52 Week Low
- BMRN $50.76
- CART $34.78
- 52 Week High
- BMRN $73.51
- CART $53.50
- Technical
- Relative Strength Index (RSI)
- BMRN 40.53
- CART 38.43
- Support Level
- BMRN $51.80
- CART $34.78
- Resistance Level
- BMRN $53.49
- CART $37.79
- Average True Range (ATR)
- BMRN 1.84
- CART 1.19
- MACD
- BMRN -0.08
- CART -0.09
- Stochastic Oscillator
- BMRN 12.58
- CART 29.80
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About CART Maplebear Inc.
Maplebear (Instacart) operates a leading grocery delivery platform in the United States and Canada. The company partners with various regional and national grocers, which offer their selection of food and other goods to customers through Instacart's ubiquitous platform. Once an item is ordered through Instacart's site, the item is picked and delivered to the customer's home by one of the platform's 600,000 shoppers, who are classified as independent contractors. Instacart earns fees based on average order value and leverages its platform's high usage to sell advertising, mainly to consumer-packaged goods companies. Instacart currently has about 8 million monthly active users (or orderers) on its platform.